Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury
Abstract Traumatic brain injury (TBI) contributes to one third of injury related deaths in the US. Treatment strategies for TBI are supportive, and the pathophysiology is not fully understood. Secondary mechanisms of injury in TBI, such as oxidative stress and inflammation, are points at which inter...
Guardado en:
Autores principales: | Evan M. Lutton, Roshanak Razmpour, Allison M. Andrews, Lee Anne Cannella, Young-Jin Son, Vladimir V. Shuvaev, Vladimir R. Muzykantov, Servio H. Ramirez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c574c0d411e41d5b652a7758170ba4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuropathology official journal of the Japanese Society of Neuropathology.
Publicado: (1993) -
Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium
por: Tong F, et al.
Publicado: (2017) - Neuropathology and applied neurobiology
-
Catalase enzyme in mitochondria of Saccharomyces cerevisiae
por: Petrova,Ventsislava Yankova, et al.
Publicado: (2002) -
Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice.
por: Eva-Verena Schaible, et al.
Publicado: (2013)